Key result
L-arginine relaxes and L-NAME contracts human Fallopian tubes, indicating a nitric oxide-dependent relaxation system.
Why the study?
The existence of a nitric oxide-mediated relaxation system in the human Fallopian tube was investigated to understand its role in tubal contractility.
Does nitric oxide mediate contractile activity in isolated strips of the human Fallopian tube?
Does nitric oxide mediate contractile activity in isolated strips of the human Fallopian tube?
This study demonstrates that a nitric oxide-dependent relaxation system exists in the human Fallopian tube, suggesting NO acts as a mediator of tubal contractility.
Answers are grounded in this paper and cite their sources.
NO may modulate human tubal contractility in vitro; leaves open any role in fertility or ectopic pregnancy.
Endogenously produced nitric oxide (NO) induces relaxation in smooth muscle in various organs. The purpose of this study was to investigate whether a NO-mediated relaxation system exists in the human Fallopian tube. To study contractility, the isthmic portion of the tube was obtained from 23 fertile women during operations due to benign non-tubal diseases. Tubal smooth muscle strips were mounted in tissue chambers containing HEPES buffer and connected to a Grass transducer for the isometric registration of contractile activity. By adding L-arginine (the substrate for NO synthesis) or N-nitro-L-arginine methyl ester (L-NAME; an inhibitor of NO synthesis) to the tissue chambers, changes in tubal contractility were monitored. The addition of L-NAME caused increased tubal contractility, while L-arginine, after an initial transient increase in tonus, caused relaxation of the strips. Using immunohistochemistry, NO synthase, the enzyme that catalyses the production of NO from L-arginine, was identified in tubal tissue cells. These results indicate that a NO-dependent relaxation system exists in the Fallopian tube and that NO may play a role as a mediator of tubal contractility.
No takes yet. Share an insight, caveat, or question.
Ekerhovd et al. (1997) studied Benign non-tubal diseases (n=23). L-arginine and L-NAME was evaluated on Tubal contractility. Addition of L-NAME increased tubal contractility, while L-arginine caused relaxation, indicating a nitric oxide-dependent relaxation system exists in the human Fallopian tube.
Synapse has enriched 10 related papers. Consider them for comparative context: